Although many questions remain to be answered, such as how olverembatinib regulates CD36 or other genes involved in lipid metabolism, the results from our study provide a new direction for revealing MOAs of TKIs in SDH-deficient GIST. Here, SDHB is linked to gastrointestinal stromal tumor.